Share
51 Posts.
lightbulb Created with Sketch. 16
clock Created with Sketch.
15/03/25
13:15
Share
Originally posted by samuelelrahi:
↑
Who are you to decide whether it is true or not? You are just a gambler like the rest of us. A desperate, cheap gambler who desperately wants in at a lower price. What “facts” have you raised to support your argument? “only 50%- 60% of Phase 3 biotech trials are successful” What does that have to do with OPT specifically? Like whoopty doo. Completely ignorant toward the intricacy in which this trial has been designed, You labelled the science, business and market opportunity as “completely irrelevant”. Without science, business and market opportunity, Opthea ceases to exist little buddy. As a pre income R&D business anxiously awaiting P3 results facing significant cash burn, the stock is naturally subject to increased volatility, short selling, institutional manipulation, DUH! You are capitalising on these factors and reframing them as something far more sinister to further your fear mongering agenda. We are all aware of the risks associated with our investment. We were aware when we bought in lower than you will ever be able to. No matter how hard you try to undermine the scientific validity of this stock, We know that you secretly want in. Whoever sells their shares to you at 45-55c is a coward. With a genuine understanding of the science, it’s difficult to entertain any doubts.
Expand
And fully agree with you by the way.